Ranbaxy Lab off 8.1% in 2 days after poor Q4 results

On BSE, 1.48 lakh shares were traded in the counter as against average daily volume of 1.31 lakh shares in the past two weeks.

The stock hit a high of Rs 418 and a low of Rs 395.90 so far during the day.

The large-cap pharmaceutical company has equity capital of Rs 211.50 crore. Face value per share is Rs 5.

Shares of Ranbaxy Laboratories have tumbled 8.11% in two trading sessions from Rs 433.15 on 25 February 2013, after the company during trading hours on Tuesday, 26 February 2013, reported poor Q4 December 2012 results.

Ranbaxy Laboratories reported a consolidated net loss of Rs 492.44 crore in Q4 December 2012, lower than net loss of Rs 2982.76 crore in Q4 December 2011. [Via]

About Our Services:

By Profession, We provide trading tips for Commodity, Equity, Stocks and futures. We are the leading brand in providing accurate tips with high accuracy.

Complete Broker Franchise available here. Get registered for free trials for any trade you want. Call us for more details and amazing offers for traders. Join us and become a professional trader.  

Mob: 9872444433, Landline: 0161-4413274, 0161-4621433

Posted in: commodity news,market news,trading news